How plant-based compounds became pharmaceuticals and why the research deserves the same attention.
A Category Problem
The phrase alternative medicine carries a specific implication. It implies a contrast with real medicine. Something used instead of conventional treatment, by people who perhaps do not fully trust science, or who prefer belief over evidence.
Herbal medicine has been placed in this category by cultural habit rather than by evidence. And that placement has caused a significant amount of genuinely useful clinical research to be dismissed before it is even read.
This article is about why that categorisation is wrong, what the actual relationship between plants and pharmaceuticals looks like, and what it means for how you think about what you put in your body.
Where Pharmaceuticals Actually Come From
Approximately 50% of the pharmaceutical drugs approved since 1981 are derived from or directly inspired by natural compounds, primarily plants. This figure comes from a landmark review by Newman and Cragg published in the Journal of Natural Products, one of the most cited papers in pharmaceutical science.
Aspirin is derived from salicylic acid, a compound found in willow bark. Willow bark was used for pain and fever for thousands of years before chemists isolated the active compound and synthesised a more stable version.
Morphine comes from the opium poppy. Digoxin, a heart medication still used today, comes from the foxglove plant. Taxol, one of the most important chemotherapy drugs in oncology, was derived from the bark of the Pacific yew tree. Metformin, the most widely prescribed diabetes medication in the world, was developed from compounds found in French lilac.
These are not alternative medicines. They are the foundation of modern pharmacology.
Why the Separation Happened
If plant compounds are the origin of so many pharmaceuticals, why does herbal medicine occupy a different cultural category?
The answer is largely commercial and regulatory rather than scientific.
In the twentieth century, pharmaceutical development became industrialised. Companies needed to patent their products to recoup the enormous costs of clinical trials and regulatory approval. Natural compounds cannot be patented. So the industry moved toward synthesised or modified versions of natural compounds that could be protected by intellectual property law.
This created a structural incentive to study synthesised drugs rather than their natural precursors, even when the natural versions had existing evidence. The research funding followed the patent potential. Herbal compounds, which anyone can grow and nobody can own, attracted less investment.
The result is a body of clinical research on herbal medicine that is smaller than its pharmaceutical equivalent, not because the plants do not work, but because the economic model of modern drug development did not prioritise studying them.
What the Research Actually Shows
The clinical evidence for herbal compounds is more substantial than most people realise. It exists in peer-reviewed journals. It uses the same methodologies as pharmaceutical research including randomised controlled trials, the highest standard of clinical evidence.
Ginger has been shown in multiple randomised controlled trials to reduce period pain to a degree equivalent to mefenamic acid, a prescription anti-inflammatory. Spearmint tea has been shown in two clinical trials to significantly reduce free testosterone in women with PCOS. Peppermint oil has been shown in a meta-analysis of nine randomised controlled trials to outperform placebo for digestive symptoms.
This is not anecdote. It is not tradition. It is controlled clinical evidence that meets the same standards applied to pharmaceutical research.
The difference is not the quality of the evidence. It is the marketing budget behind communicating it.
What This Means for Tea Lab
Tea Lab was built on a specific premise: that the evidence for herbal medicine deserves to be read, understood, and applied with the same rigour applied to pharmaceutical research.
Every ingredient in every Tea Lab formula was selected because clinical evidence exists for its mechanism of action. Not because it has been used for centuries, though in many cases it has. Not because it is natural, which is not by itself a meaningful health claim. Because the trials have been done, the mechanisms are understood, and the evidence is consistent.
Herbal medicine is not alternative medicine. It is medicine. The distinction matters, and it is the foundation on which Tea Lab was built.
Sources
Newman, D. J., & Cragg, G. M. (2020). Natural products as sources of new drugs over the nearly four decades. Journal of Natural Products, 83(3), 770–803.
Rates, S. M. K. (2001). Plants as source of drugs. Toxicon, 39(5), 603–613.
Ozgoli, G., Goli, M., & Moattar, F. (2009). Comparison of effects of ginger, mefenamic acid, and ibuprofen on pain in women with primary dysmenorrhea. Journal of Alternative and Complementary Medicine, 15(2), 129–132.
Grant, P. (2010). Spearmint herbal tea has significant anti-androgen effects in polycystic ovarian syndrome. Phytotherapy Research, 24(2), 186–188.
Khanna, R., MacDonald, J. K., & Levesque, B. G. (2014). Peppermint oil for the treatment of irritable bowel syndrome. Journal of Clinical Gastroenterology, 48(6), 505–512.